Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases.
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?
Spatial modeling of multiple sclerosis for disease subtype prediction.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Sedentary behavior is associated with disability status and walking performance, but not cognitive function, in multiple sclerosis.
Robotic-Assisted Gait Training in Neurological Patients: Who May Benefit?
Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.
Physiological variation of retinal layer thickness is not caused by hydration: A randomised trial.
Vitamin D in allergic disorders.
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Neuropathic pain: diagnosis and treatment.
Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
486
487
488
489
490
491
492
493
494
…
next ›
last »